d-alpha tocopherol has been researched along with pentoxifylline in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.43) | 18.7374 |
1990's | 7 (10.00) | 18.2507 |
2000's | 23 (32.86) | 29.6817 |
2010's | 29 (41.43) | 24.3611 |
2020's | 10 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Morita, M; Naito, Y; Niki, E; Yoshikawa, T | 1 |
Baluda, VP; Iashvili, BP; Kamkamidze, MV; Katsitadze, NG; Kozelskaya, LV; Lukhoyanova, TI; Robakidze, TA | 1 |
Gottlöber, P; Korting, HC; Krähn, G; Peter, RU; Stock, W | 1 |
Bekerecioğlu, M; Demirtaş, I; Karaayvaz, M; Kutluhan, A | 1 |
Delanian, S | 1 |
Atger, V; Cogny, A; Lenoble, M; Moatti, N; Paul, JL; Surbled, B | 1 |
Delanian, S; Lefaix, JL; Leplat, JJ; Martin, M; Tricaud, Y; Vozenin, MC | 1 |
Golovanov, SA; Ianenko, EK; Kazachenko, AV; Kirpatovskiĭ, VI; Kovalenko, EA | 1 |
Balla-Mekias, S; Delanian, S; Lefaix, JL | 1 |
Akpolat, I; Akpolat, T; Bedir, A; Coşar, AM; Kandemir, B; Oztürk, H; Sarikaya, S | 1 |
Gottlöber, P; Krähn, G; Peter, RU | 1 |
Cornes, P; Earl, J; Gothard, L; Hall, E; MacLaren, J; Mortimer, P; Peacock, J; Peckitt, C; Woods, M; Yarnold, J | 1 |
Chiao, TB; Lee, AJ | 1 |
Dávila-Esqueda, ME; Martínez-Morales, F; Vertiz-Hernández, AA | 1 |
Jia, JD; Zhang, FK; Zhang, JY | 1 |
Bay Karabulut, A; Mizrak, B; Uguralp, S | 1 |
Laurent, C; Pouget, JP; Voisin, P | 2 |
Brooker, S; Cornes, P; Earl, J; Glees, J; Gothard, L; Hall, E; Peckitt, C; Tait, D; Yarnold, J | 1 |
Amouzegar-Hashemi, F; Haddad, P; Kalaghchi, B | 1 |
Comar, KM; Sterling, RK | 1 |
Altundag, K; Elgin, Y; Erkal, H; Misirlioglu, CH; Ugur, I | 1 |
Altug, T; Arbak, S; Bese, NS; Munzuroglu, F; Ober, A; Sut, N; Uslu, B; Yesiladali, G | 1 |
Aydemir, O; Ozercan, IH; Ustundağ, B; Yilmaz, T | 1 |
Altundag, K; Demirkasimoglu, T; Kucukplakci, B; Misirlioglu, CH; Sanri, E | 1 |
Harrison, C; Jellett, L; McAleese, J | 1 |
Bonnafoux-Clavère, A; Bonnetblanc, JM; Clavère, P | 1 |
Boerma, M; Hauer-Jensen, M; Roberto, KA | 1 |
Borges, CT; de Souza, RB; Kuruma, KA; Macedo, AR; Macedo, PA | 1 |
Höglund, P; Johansson, K; Jönsson, C; Killander, F; Kjellén, E; Magnusson, M; Malmström, P; Weddig, A | 1 |
Abdulwahid Arif, I; Al Kadasah, S; Al Moutaery, K; Al Mutairy, A; Khan, HA; Siddiquei, M; Tariq, M | 1 |
Acharya, S; Balen, AH; Yasmin, E | 1 |
Abdollahi, M; Baeeri, M; Ghahremani, MH; Ghazi-Khansari, M; Golestani, A; Ranjbar, A; Sharifzadeh, M | 1 |
Berenson, JR; Epstein, JB; Epstein, MS; Gorsky, M; Wicknick, FW | 1 |
Breyer, BN; Clavijo, RI; Eisenberg, ML; Flechner, L; Huang, YC; Lue, TF; Shindel, AW; Smith, JF | 1 |
Berbée, M; Fu, Q; Garg, S; Hauer-Jensen, M; Kulkarni, S; Kumar, KS | 1 |
Larsen, SM; Levine, LA | 1 |
Garrett, N; Kahenasa, N; Kelly, J; Nabili, V; Nishimura, I; Sung, EC | 1 |
Bhatia, S; Bodeker, K; Buatti, J; Button, AM; Jacobson, G; Smith, BJ | 1 |
Nabil, S | 1 |
Delanian, S; Gilbert-Sirieix, M; Hamama, S; Vozenin, MC | 1 |
Delanian, S; Gervaz, P; Hamama, S; Noman, MZ; Vozenin, MC | 1 |
Bozkurt, KK; Demırpence, Ö; Doğuç, DK; Kaya, V; Şen, CA; Süren, D; Yalçın, AY; Yazkan, R; Yıldırım, M; Yüksel, Ö | 1 |
Loomba, R; Pearlman, M | 1 |
Brennan, PA; Kumar, R; Lyons, A; Osher, J; Warner, E | 1 |
Hellstrom, WJ; Mitchell, GC; Sangkum, P; Tan, RB | 1 |
Janovszky, Á; Piffkó, J; Szabó, A; Vereb, T | 1 |
Aburn, N; Lee, R; MacKinnon, CA; Tan, ST | 1 |
Corey, KE; Rinella, ME | 1 |
Cook, M; Glissmeyer, M; Johnson, N; Schray, M; Sorenson, L; Zegzula, HD | 1 |
Ganesh, S; Rustgi, VK | 1 |
Chaiyakunapruk, N; Chongmelaxme, B; Kowdley, KV; Phisalprapa, P; Saokaew, S; Sawangjit, R; Thakkinstian, A | 1 |
Bush, H; Golabi, P; Younossi, ZM | 1 |
Mao, YM; Tang, JT | 1 |
Jones, EL; Kaidar-Person, O; Marks, LB | 1 |
Jayaram, R; Thavarajah, M | 1 |
Eo, MY; Kim, SM; Lee, JH; Myoung, H; Nguyen, TTH; Seo, MH | 1 |
El Wakeel, L; El-Hamamsy, M; Kelany, M; Saad, AS; Sayed, R | 1 |
Chen, Y; Jia, J; Tian, L; Xiao, W; Zhang, Z; Zhao, L; Zong, C | 1 |
Atkin, SL; De Vincentis, A; Jamialahmadi, T; Mahjoubin-Tehran, M; Mantzoros, CS; Mikhailidis, DP; Sahebkar, A | 1 |
Bhardwaj, A; Bihari, C; Kedarisetty, CK; Kumar, G; Kumar, M; Rastogi, A; Sarin, SK | 1 |
Abed, H; Banjar, A; Patel, V | 1 |
Beheshti, S; Cheng, H; Kwok, J; Patel, V; Samani, M; Sproat, C | 1 |
Abdelaziz, AE; Abdelkawy, KS; Ali, AA; Elbarbry, F; Fouda, A; Hussien, M | 1 |
Andreis, JD; Claudino, M; Delfrate, G; Fernandes, D; Franco, GCN; Lipinski, LC; Mecca, LEA; Mroczek, T | 1 |
Dong, X; Feng, G; Gao, B; Liu, Y; Qian, S; Ren, S; Yao, C | 1 |
Altundag, K | 1 |
Cape, A; Kwok, J; Mahendran, K; Mellor, A; Patel, V; Sproat, C; Young, H | 1 |
20 review(s) available for d-alpha tocopherol and pentoxifylline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report].
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Therapy, Combination; Female; Fibrosis; Humans; Middle Aged; Neoplasms, Radiation-Induced; Pentoxifylline; Radiodermatitis; Radiotherapy, Adjuvant; Skin; Skin Ulcer; Vitamin E | 1996 |
[Cutaneous radiation syndrome: clinical features, diagnosis and therapy].
Topics: Adrenal Cortex Hormones; Adult; Brazil; Female; Free Radical Scavengers; Georgia (Republic); Humans; Interferon-gamma; Male; Pentoxifylline; Radiation Dosage; Radiation-Protective Agents; Radioactive Hazard Release; Radiodermatitis; Superoxide Dismutase; Syndrome; Time Factors; Ukraine; Vitamin E | 2000 |
Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis.
Topics: Antioxidants; Clinical Trials as Topic; Drug Therapy, Combination; Fibrosis; Humans; Pentoxifylline; Platelet Aggregation Inhibitors; Radiation Injuries; Vitamin E | 2005 |
Treatment of patients with alcoholic liver disease.
Topics: Adrenal Cortex Hormones; Antioxidants; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis, Alcoholic; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Liver Function Tests; Male; Nutritional Support; Pentoxifylline; Prognosis; Risk Assessment; Severity of Illness Index; Silymarin; Survival Rate; Treatment Outcome; Tumor Necrosis Factor-alpha; Vitamin E | 2005 |
Review article: Drug therapy for non-alcoholic fatty liver disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Betaine; Cholagogues and Choleretics; Enzyme Inhibitors; Fatty Liver; Humans; Hypoglycemic Agents; Lipotropic Agents; Metformin; Pentoxifylline; Probucol; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2006 |
Peyronie's disease: review of nonsurgical treatment options.
Topics: 4-Aminobenzoic Acid; Calcium Channel Blockers; Carnitine; Colchicine; Collagenases; Combined Modality Therapy; Contraindications; Electroconvulsive Therapy; Humans; Interferons; Iontophoresis; Male; Penile Induration; Pentoxifylline; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tamoxifen; Traction; Vitamin E | 2011 |
State of the art: treatment of nonalcoholic steatohepatitis.
Topics: Antioxidants; Exercise; Humans; Hypoglycemic Agents; Life Style; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Thiazolidinediones; Vitamin E; Weight Loss | 2014 |
Update on medical management of Peyronie's disease.
Topics: 4-Aminobenzoic Acid; Administration, Topical; Adrenal Cortex Hormones; Disease Management; High-Energy Shock Waves; Humans; Interferon alpha-2; Interferon-alpha; Iontophoresis; Male; Penile Induration; Pentoxifylline; Radiotherapy; Recombinant Proteins; Stem Cell Transplantation; Traction; Ubiquinone; Vasodilator Agents; Verapamil; Vitamin E; Vitamins | 2014 |
[Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
Topics: alpha-Tocopherol; Analgesics; Anti-Bacterial Agents; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Debridement; Early Diagnosis; Humans; Laser Therapy; Low-Level Light Therapy; Ozone; Pentoxifylline; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Saliva; Severity of Illness Index; Teriparatide | 2014 |
Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
Topics: Antioxidants; Bariatric Surgery; Exercise; Fatty Acids, Omega-6; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Thiazolidinediones; Vitamin E | 2016 |
Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
Topics: Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Anticholesteremic Agents; Antioxidants; Cannabinoid Receptor Antagonists; Cholagogues and Choleretics; Fatty Acids, Omega-3; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Pentoxifylline; Piperidines; Probiotics; Pyrazoles; Rimonabant; Synbiotics; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2016 |
Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.
Topics: Antioxidants; Chenodeoxycholic Acid; Humans; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Thiazolidinediones; Treatment Outcome; Vitamin E | 2016 |
Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Topics: Antioxidants; Chenodeoxycholic Acid; Cholic Acids; Diet Therapy; Exercise; Free Radical Scavengers; Humans; Hypoglycemic Agents; Life Style; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Vitamin E | 2017 |
Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence.
Topics: Antioxidants; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazolidinediones; Vitamin E | 2017 |
Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
Topics: Breast Neoplasms; Female; Fibrosis; Humans; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Radiotherapy, Adjuvant; Vitamin E | 2018 |
RETRACTED: The effect of combined application of pentoxifylline and vitamin E for the treatment of osteoradionecrosis of the jaws: a meta-analysis.
Topics: Humans; Hyperbaric Oxygenation; Jaw; Osteoradionecrosis; Pentoxifylline; Vitamin E | 2020 |
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis.
Topics: Biopsy; Disease Progression; Humans; Liver; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review.
Topics: Clodronic Acid; Drug Therapy, Combination; Humans; Observational Studies as Topic; Osteoradionecrosis; Pentoxifylline; Randomized Controlled Trials as Topic; Retrospective Studies; Tocopherols; Vitamin E | 2023 |
Antioxidants for Treatment of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis.
Topics: Antioxidants; Flavonoids; Humans; Muscular Dystrophy, Duchenne; Penicillamine; Pentoxifylline; Quality of Life; Superoxide Dismutase; Vitamin E | 2022 |
12 trial(s) available for d-alpha tocopherol and pentoxifylline
Article | Year |
---|---|
Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Humans; Lymphedema; Mastectomy; Middle Aged; Pentoxifylline; Probability; Quality of Life; Radiotherapy Dosage; Radiotherapy, Adjuvant; Reference Values; Risk Assessment; Treatment Outcome; Vitamin E | 2004 |
Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Patient Compliance; Pelvic Neoplasms; Pentoxifylline; Quality of Life; Radiotherapy; Vitamin E | 2005 |
Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antioxidants; Child; Female; Humans; Male; Middle Aged; Pentoxifylline; Radiation Pneumonitis; Radiation-Protective Agents; Severity of Illness Index; Treatment Outcome; Vitamin E | 2005 |
Effect of concomitant use of pentoxifylline and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer: a randomized prospective clinical trial.
Topics: Adult; Aged; alpha-Tocopherol; Antioxidants; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pentoxifylline; Prospective Studies; Radiation-Protective Agents; Radiotherapy Dosage; Survival Rate | 2006 |
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer.
Topics: Adult; Aged; alpha-Tocopherol; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Nausea; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Statistics, Nonparametric; Treatment Outcome; Vomiting | 2007 |
Pentoxyphylline in association with vitamin E reduces cutaneous fibrosis in systemic sclerosis.
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Fibrosis; Humans; Male; Middle Aged; Pentoxifylline; Scleroderma, Systemic; Skin; Treatment Outcome; Vasodilator Agents; Vitamin E | 2009 |
Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Topics: Aged; Antioxidants; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Middle Aged; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage; Radiotherapy, Adjuvant; Sweden; Treatment Outcome; Vitamin E | 2009 |
Pentoxifylline treatment and penile calcifications in men with Peyronie's disease.
Topics: Adult; Aged; Calcinosis; Cohort Studies; Humans; Male; Middle Aged; Penile Induration; Penis; Pentoxifylline; Phosphodiesterase Inhibitors; Retrospective Studies; Treatment Outcome; Ultrasonography; Vitamin E | 2011 |
Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Compliance; Drug Therapy, Combination; Female; Fibrosis; Humans; Middle Aged; Pentoxifylline; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Vitamin E | 2013 |
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Radiotherapy; Stomatitis; Vitamin E | 2019 |
Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
Topics: Adolescent; Adult; Alanine Transaminase; Antioxidants; Drug Therapy, Combination; Female; Humans; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Pilot Projects; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Vitamin E; Young Adult | 2021 |
A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
Topics: Adult; Antioxidants; Cholagogues and Choleretics; Disease Progression; Egypt; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Single-Blind Method; Treatment Outcome; Ursodeoxycholic Acid; Vitamin E | 2021 |
38 other study(ies) available for d-alpha tocopherol and pentoxifylline
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of plasma lipid oxidation induced by peroxyl radicals, peroxynitrite, hypochlorite, 15-lipoxygenase, and singlet oxygen by clinical drugs.
Topics: Animals; Antioxidants; Antipyrine; Arachidonate 15-Lipoxygenase; Edaravone; Free Radicals; Hypochlorous Acid; Lipid Metabolism; Lipids; Mice; Oxidants; Oxidation-Reduction; Peroxides; Peroxynitrous Acid; Plasma; Probucol; Singlet Oxygen | 2016 |
The effects of administration of drugs influencing haemostasis during treatment of patients with burns.
Topics: Adolescent; Adult; Antithrombin III; Aprotinin; Burns; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Hemostasis; Heparin; Humans; Male; Microcirculation; Middle Aged; Niacin; Pentoxifylline; Phytic Acid; Time Factors; Vitamin E; Wound Healing | 1986 |
Prevention of adriamycin-induced skin necrosis with various free radical scavengers.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Flavonoids; Free Radical Scavengers; Ginkgo biloba; Male; Malondialdehyde; Necrosis; Pentoxifylline; Plant Extracts; Rats; Rats, Sprague-Dawley; Skin; Skin Ulcer; Vitamin E | 1998 |
Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol.
Topics: Aged; Drug Therapy, Combination; Female; Fibrosis; Humans; Pentoxifylline; Radiation Injuries; Radiotherapy, High-Energy; Thyroid Neoplasms; Vasodilator Agents; Vitamin E | 1998 |
Oxidative modification of high-density lipoprotein 3 induced by human polymorphonuclear neutrophils. Protective effect of pentoxifylline.
Topics: Antioxidants; Apolipoprotein A-I; Dose-Response Relationship, Drug; Humans; Lipoproteins, HDL; Lipoproteins, HDL3; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Pentoxifylline; Respiratory Burst; Tetradecanoylphorbol Acetate; Thiobarbituric Acid Reactive Substances; Vitamin E | 1999 |
Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study.
Topics: Drug Combinations; Fibrosis; Gamma Rays; Humans; Muscle, Skeletal; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Skin; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vitamin E | 1999 |
[Enhancement of the anti-ischemic kidney resistance by adaptive hypoxic conditioning and drug therapy].
Topics: Adaptation, Physiological; Animals; Antioxidants; Drug Synergism; Female; Hypoxia; Ischemia; Liver; Male; Pentoxifylline; Rabbits; Reperfusion; Vitamin E | 1999 |
Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol.
Topics: Adult; Aged; Breast Neoplasms; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pentoxifylline; Pulmonary Fibrosis; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Treatment Outcome; Vitamin E | 1999 |
Effect of vitamin E and pentoxifylline on glycerol-induced acute renal failure.
Topics: Acute Kidney Injury; Animals; Creatine Kinase; Creatinine; Disease Models, Animal; Glycerol; Kidney Tubules; Pentoxifylline; Rats; Rats, Sprague-Dawley; Urea; Vitamin E | 2000 |
Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Kidney; Lipid Peroxidation; Male; Models, Animal; Oxidative Stress; Pentoxifylline; Rats; Rats, Sprague-Dawley; Streptozocin; Vitamin E | 2005 |
Effects of pentoxifylline and vitamin E on the bilateral ovary after experimental ovarian ischemia.
Topics: Animals; Antioxidants; Female; Ischemia; Models, Animal; Ovarian Diseases; Ovary; Pentoxifylline; Rats; Rats, Wistar; Reperfusion Injury; Torsion Abnormality; Treatment Outcome; Vasodilator Agents; Vitamin E | 2005 |
Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to Gamma rays.
Topics: alpha-Tocopherol; Cell Cycle; Cell Survival; Cells, Cultured; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Fibroblasts; Humans; Pentoxifylline; Radiation-Protective Agents; Reactive Oxygen Species; Skin Physiological Phenomena | 2005 |
DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol.
Topics: alpha-Tocopherol; Antioxidants; Cells, Cultured; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Combinations; Endothelial Cells; Female; Gamma Rays; Humans; Microcirculation; Middle Aged; Pentoxifylline; Radiation Dosage; Radiation Tolerance; Radiation-Protective Agents; Skin | 2006 |
Vitamin E protects against the development of radiation-induced pulmonary fibrosis in rats.
Topics: Animals; Antioxidants; Dietary Supplements; Drug Therapy, Combination; Female; Fibrosis; Free Radical Scavengers; Lung Neoplasms; Neoplasms, Radiation-Induced; Pentoxifylline; Radiation Dosage; Rats; Rats, Wistar; Vitamin E | 2007 |
Effects of vitamin e, pentoxifylline and aprotinin on light-induced retinal injury.
Topics: Animals; Antioxidants; Aprotinin; Drug Therapy, Combination; Eye Burns; Guinea Pigs; Injections, Intraperitoneal; Light; Male; Malondialdehyde; Pentoxifylline; Radiation Injuries, Experimental; Radiation-Protective Agents; Retina; Retinal Diseases; Serine Proteinase Inhibitors; Spectrophotometry; Treatment Outcome; Vitamin E | 2007 |
Letter to editor. Re: "Effect of concomitant use of pentoxifylline (PTX) and alpha-tocopherol with radiotherapy on the clinical outcome of patients with stage IIIB non-small cell lung cancer".
Topics: alpha-Tocopherol; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Therapy, Combination; Humans; Lung; Lung Diseases; Lung Neoplasms; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Treatment Outcome | 2007 |
[Radiation induced skin reactions].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Age Factors; Anti-Ulcer Agents; Humans; Hyaluronic Acid; Pentoxifylline; Radiation-Protective Agents; Radiodermatitis; Risk Factors; Sucralfate; Time Factors; Vitamin E | 2008 |
Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol.
Topics: alpha-Tocopherol; Animals; Cell Count; Collagen Type I; Collagen Type III; Cytoskeleton; Diastole; Fibrosis; Heart; Male; Mast Cells; Myocardium; Pentoxifylline; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley | 2008 |
Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Glutathione; Male; Motor Activity; Neurotoxicity Syndromes; Nitriles; Oxidative Stress; Pentoxifylline; Rats; Rats, Sprague-Dawley; Reflex; Vitamin E | 2009 |
The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies--a report of 20 cases.
Topics: Adult; Antioxidants; Dietary Supplements; Endometrium; Female; Humans; Infertility, Female; Pentoxifylline; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome; Uterine Diseases; Vasodilator Agents; Vitamin E; Young Adult | 2009 |
Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain.
Topics: alpha-Tocopherol; Animals; Biomarkers; Brain; Chemoprevention; Drug Therapy, Combination; Free Radical Scavengers; Insecticides; Lipid Peroxidation; Malathion; Male; Mitochondria; Oxidative Stress; Oxidoreductases; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tyrosine | 2010 |
Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Tocopherol; Anti-Infective Agents, Local; Antioxidants; Bone Density Conservation Agents; Chlorhexidine; Diphosphonates; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Injections, Intravenous; Jaw Diseases; Male; Middle Aged; Mouthwashes; Osteonecrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Treatment Outcome | 2010 |
Pentoxifylline enhances the radioprotective properties of γ-tocotrienol: differential effects on the hematopoietic, gastrointestinal and vascular systems.
Topics: Animals; Blood Vessels; Chromans; Drug Synergism; Enzyme Inhibitors; Hematopoiesis; Intestines; Male; Mice; Oxidative Stress; Pentoxifylline; Peroxynitrous Acid; Radiation Injuries; Radiation-Protective Agents; Survival Analysis; Vascular System Injuries; Vitamin E; Whole-Body Irradiation | 2011 |
Resolution of pain and complete healing of mandibular osteoradionecrosis using pentoxifylline and tocopherol: a case report.
Topics: Aged; alpha-Tocopherol; Antioxidants; Cranial Irradiation; Drug Combinations; Humans; Male; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Redefining osteoradionecrosis.
Topics: alpha-Tocopherol; Antioxidants; Humans; Male; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline | 2012 |
Radiation-induced enteropathy: molecular basis of pentoxifylline-vitamin E anti-fibrotic effect involved TGF-β1 cascade inhibition.
Topics: Adult; Aged; Algorithms; Antioxidants; Blotting, Western; Clinical Trials as Topic; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Humans; Immunohistochemistry; Intestinal Diseases; Male; Middle Aged; Pentoxifylline; Radiation-Protective Agents; Radiotherapy; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Treatment Outcome; Vitamin E | 2012 |
MiR-210: A potential therapeutic target against radiation-induced enteropathy.
Topics: alpha-Tocopherol; Antioxidants; Cells, Cultured; Drug Therapy, Combination; Fibrosis; Humans; Hypoxia; Intestinal Diseases; MicroRNAs; Molecular Targeted Therapy; Myocytes, Smooth Muscle; Pentoxifylline; Platelet Aggregation Inhibitors; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; RNA; RNA, Mitochondrial | 2014 |
The relation of radiation-induced pulmonary fibrosis with stress and the efficiency of antioxidant treatment: an experimental study.
Topics: Animals; Antioxidants; Ascorbic Acid; Histological Techniques; Pentoxifylline; Pulmonary Fibrosis; Radiation Injuries, Experimental; Radiotherapy; Rats; Statistics, Nonparametric; Stress, Physiological; Treatment Outcome; Vitamin E | 2014 |
Osteoradionecrosis--a review of current concepts in defining the extent of the disease and a new classification proposal.
Topics: Antioxidants; Free Radical Scavengers; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Osteoradionecrosis; Pentoxifylline; Surgical Flaps; Vitamin E | 2014 |
Orbital immunoglobulin IgG4-related inflammatory fibrosclerosing lesion treated with pentoxifylline and α-tocopherol: case report.
Topics: Adult; alpha-Tocopherol; Anti-Inflammatory Agents; Antioxidants; Autoimmune Diseases; B-Lymphocytes; Eosinophils; Female; Fibroblasts; Fibrosis; Free Radical Scavengers; Humans; Immunoglobulin G; Lymphocytes; Orbital Diseases; Orbital Pseudotumor; Pentoxifylline; Plasma Cells; Sclerosis; T-Lymphocytes | 2015 |
Prophylactic use of pentoxifylline (Trental) and vitamin E to prevent capsular contracture after implant reconstruction in patients requiring adjuvant radiation.
Topics: Adult; Breast Implantation; Breast Implants; Breast Neoplasms; Cohort Studies; Drug Therapy, Combination; Female; Humans; Implant Capsular Contracture; Mastectomy; Middle Aged; Pentoxifylline; Postoperative Period; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vitamin E | 2016 |
Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bone Density Conservation Agents; Free Radical Scavengers; Humans; Male; Mandible; Osteonecrosis; Pentoxifylline; Prostatic Neoplasms; Vitamin E; Zoledronic Acid | 2019 |
Effects of pentoxifylline and tocopherol on a rat-irradiated jaw model using micro-CT cortical bone analysis.
Topics: Animals; Antioxidants; Bone Diseases, Metabolic; Cortical Bone; Fibrosis; Male; Mandible; Osteoradionecrosis; Pentoxifylline; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Tocopherols; Treatment Outcome; Vitamin E; X-Ray Microtomography | 2019 |
Prophylactic pentoxifylline and vitamin E use for dental extractions in irradiated patients with head and neck cancer.
Topics: Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Retrospective Studies; Tooth Extraction; Vitamin E | 2022 |
Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction.
Topics: alpha-Tocopherol; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Osteonecrosis; Pentoxifylline; Rats; Rats, Wistar; Tooth Extraction | 2022 |
The use of pentoxifylline might enhance the effect of chemotherapy or radiotherapy in reducing tumor growth.
Topics: Humans; Lymphocytes, Tumor-Infiltrating; Neoplasms; Pentoxifylline; Radiation Oncology; Vitamin E | 2023 |
The use of liquid formulation pentoxifylline and vitamin E in both established and as a prophylaxis for dental extractions "at risk" of osteoradionecrosis.
Topics: Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Retrospective Studies; Tooth Extraction; Vitamin E | 2023 |